Ignite Creation Date:
2024-05-05 @ 11:23 PM
Last Modification Date:
2024-10-26 @ 10:33 AM
Study NCT ID:
NCT01316939
Status:
TERMINATED
Last Update Posted:
2017-09-07
First Post:
2011-03-03
Brief Title:
GSK1605786A in the Maintenance of Remission in Subjects With Crohns Disease
Sponsor:
GlaxoSmithKline
Organization:
GlaxoSmithKline
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Crohns Disease |
Keywords:
| Name | View |
|---|---|
| Crohns disease oral CCR9 antagonist placebo-controlled maintenance of remission 52-week treatment quality of life | View |